Risk Factors of Malignant Glaucoma Occurrence after Glaucoma Surgery.
Risk Factors of Malignant Glaucoma Occurrence after Glaucoma Surgery.
复制标题
DOI：
10.1155/2017/9616738
复制
发表时间：
2017
影响因子：
1.9
通讯作者：
Rękas M
中科院分区：
文献类型：
--
作者：
Krix-Jachym K;Żarnowski T;Rękas M
本研究的目的是双重的：第一，评估发生恶性青光眼的诱发因素，第二，根据原发性青光眼手术的类型，比较恶性青光眼的发生率。 回顾性分析了1689例单独或联合超声乳化的青光眼手术患者。收集的数据包括手术类型、滤过角宽度、术后是否存在恶性青光眼以及从初次手术到恶性青光眼发生的时间。 恶性青光眼22眼，占所有手术病例的1.3%。从青光眼手术到恶性青光眼发生的平均时间为61.4 ± 190.5天。在穿透性手术的患者中，2.3%的患者发生恶性青光眼，而在非穿透性手术后，未发现此类并发症（p = 0.00004）。虹膜角膜角浅的患者更常发生恶性青光眼（p = 0.0013）。 恶性青光眼的发生与青光眼手术的穿透性有关，青光眼手术后会出现这种并发症，并且在虹膜角膜角较浅的眼睛中发生率较高。小梁切除术后恶性青光眼的风险与虹膜切除术相比，以及超声乳化小梁切除术后与超声乳化虹膜切除术相比是相当的。
The aim of this study was twofold: first, to evaluate the predisposing factors for occurrence of malignant glaucoma and second, to compare frequency of malignant glaucoma depending on the type of primary glaucoma surgery. Retrospective analysis was performed in 1689 consecutive patients who underwent glaucoma surgery alone or combined with phacoemulsification. Data collected included the type of surgery, width of the filtration angle, presence or absence of malignant glaucoma in the postoperative period, and time from the primary surgery to malignant glaucoma occurrence. Malignant glaucoma occurred in 22 eyes that amounted to 1.3% of cases among all surgery performed. Mean time from glaucoma surgery to malignant glaucoma occurrence was 61.4 ± 190.5 days. Among patients with penetrating surgery, malignant glaucoma occurred in 2.3% of patients, whereas after nonpenetrating operations, such complication was not found (p = 0.00004). Malignant glaucoma occurred more often in patients with shallow iridocorneal angle (p = 0.0013). The risk of malignant glaucoma development is associated with penetrating characteristic of glaucoma surgery, after which this complication appears and its occurrence is higher in eyes with shallow iridocorneal angle. The risk of malignant glaucoma after trabeculectomy compared to iridencleisis as well as after phacotrabeculectomy compared to phacoiridencleisis is equivalent.
登录
查看更多内容
影响因子：
4.1
作者：
Ruben, S;Tsai, J;Hitchings, R
通讯作者：
Hitchings, R
影响因子：
4.1
作者：
Foster, P. J.;Broadway, D. C.;Khaw, K-T
通讯作者：
Khaw, K-T
影响因子：
2
作者：
Quigley, HA;Friedman, DS;Congdon, NG
通讯作者：
Congdon, NG
影响因子：
1.9
作者：
Rekas, Marek;Krix-Jachym, Karolina;Zarnowski, Tomasz
通讯作者：
Zarnowski, Tomasz
影响因子：
4.2
作者：
LIPPAS, J
通讯作者：
LIPPAS, J